Boothbay Fund Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$257K Sell
2,396
-1,500
-39% -$161K 0.01% 975
2025
Q1
$393K Sell
3,896
-32,238
-89% -$3.25M 0.01% 800
2024
Q4
$3.23M Sell
36,134
-68,182
-65% -$6.09M 0.08% 277
2024
Q3
$8.74M Buy
104,316
+57,846
+124% +$4.85M 0.2% 99
2024
Q2
$3.58M Buy
46,470
+11,974
+35% +$922K 0.08% 270
2024
Q1
$2.36M Buy
34,496
+23,917
+226% +$1.64M 0.05% 369
2023
Q4
$612K Sell
10,579
-107,937
-91% -$6.24M 0.02% 776
2023
Q3
$6.26M Sell
118,516
-18,755
-14% -$990K 0.15% 118
2023
Q2
$7.42M Sell
137,271
-60,241
-30% -$3.26M 0.16% 96
2023
Q1
$9.88M Sell
197,512
-80,532
-29% -$4.03M 0.2% 60
2022
Q4
$12.9M Sell
278,044
-151,350
-35% -$7M 0.3% 22
2022
Q3
$16.6M Buy
429,394
+22,180
+5% +$859K 0.42% 11
2022
Q2
$15.2M Buy
407,214
+174,581
+75% +$6.51M 0.4% 12
2022
Q1
$10.3M Buy
232,633
+68,301
+42% +$3.02M 0.24% 39
2021
Q4
$6.98M Buy
164,332
+30,785
+23% +$1.31M 0.16% 100
2021
Q3
$5.8M Buy
133,547
+100,622
+306% +$4.37M 0.16% 94
2021
Q2
$1.41M Sell
32,925
-7,283
-18% -$311K 0.05% 468
2021
Q1
$1.55M Sell
40,208
-138,792
-78% -$5.36M 0.06% 329
2020
Q4
$6.44M Buy
179,000
+154,745
+638% +$5.56M 0.24% 47
2020
Q3
$927K Sell
24,255
-4,592
-16% -$176K 0.06% 392
2020
Q2
$1.01M Buy
28,847
+2,536
+10% +$89.1K 0.07% 312
2020
Q1
$859K Buy
+26,311
New +$859K 0.07% 289
2019
Q4
Sell
-6,253
Closed -$254K 755
2019
Q3
$254K Buy
+6,253
New +$254K 0.02% 519
2018
Q4
Sell
-5,600
Closed -$216K 602
2018
Q3
$216K Buy
+5,600
New +$216K 0.02% 514
2018
Q1
Sell
-14,786
Closed -$367K 593
2017
Q4
$367K Buy
+14,786
New +$367K 0.05% 303
2016
Q3
Sell
-14,496
Closed -$339K 625
2016
Q2
$339K Buy
+14,496
New +$339K 0.13% 181
2015
Q4
Sell
-12,800
Closed -$210K 530
2015
Q3
$210K Buy
+12,800
New +$210K 0.1% 285